Key result
Intracellular pH gates inward-rectifier K+ channels (Kir1.1 and Kir4.1) via protonation of a lysine residue, a mechanism disrupted by mutations in hyperprostaglandin E syndrome.
This review elucidates the molecular mechanism of intracellular pH-gating in Kir channels and explains how specific point mutations lead to channel inactivation in hyperprostaglandin E syndrome.
Answers are grounded in this paper and cite their sources.
May guide targeted therapies in hyperprostaglandin E syndrome; leaves open clinical translation of pH-gating mechanisms.
Inward rectifier K+ channels of the Kir1.1 (ROMK) and Kir4.1 subtype are predominantly expressed in epithelial cells where they are responsible for K+ transport across the plasma membrane. Uniquely among the members of the Kir family, these channels are gated by intracellular pH in the physiological range. pH-gating involves structural rearrangements in cytoplasmic domains and the P-loop of the Kir protein. The energy for the gating transition is delivered by protonation of a lysine residue that is located prior to the first transmembrane segment and serves as a 'pH sensor'. The anomalous titration required for lysine operating in the neutral pH range results from its close interaction with two positively charged arginines from the distant N- and C-termini termed the R/K/R triad. Disturbance of this triad as results from a number of point mutations found in patients with hyperprostaglandin E syndrome (HPS) increases the pKa of the pH sensor and results in channels being permanently inactivated under physiological conditions. This article will focus on the mechanism of pH-gating, its implications for the tertiary structure of Kir proteins and on its significance for the pathogenesis of HPS.
No takes yet. Share an insight, caveat, or question.
Schulte et al. (2000) conducted a review in Hyperprostaglandin E syndrome (HPS). Intracellular pH was evaluated. Intracellular pH gates inward-rectifier K+ channels (Kir1.1 and Kir4.1) via protonation of a lysine residue, a mechanism disrupted by mutations in hyperprostaglandin E syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: